top of page
Search

The Golden Age of Medical Cannabis: Part IV - Navigating the Cannabis Landscape for Seniors

Updated: Apr 21

A Series Dedicated to Medical Cannabis: Rediscovering Cannabis as a Healing Plant.


April 20th 2026


Cannabis Doctors of New York Focuses on Practical Logistics, Financial Aid, and Trusted Medical Partnerships.


FROM THEORY TO ACTION: You now understand the history (Part I), the safety protocols (Part II), and the clinical future (Part III). But knowledge is only half the battle. The other half is action. For many seniors, the biggest barrier isn't fear of the plant—it's fear of the process. How do I walk into a dispensary? How do I pay for it? Who do I trust with my health? This Field Guide is your map. It cuts through the confusion and points you toward the resources that work. And one individual who knows this map very well stands as your trusted partner: Cannabis Doctors of New York’s Dr. Kenneth Wienberg.


SECTION 1: THE DISPENSARY GUIDE Walking into a cannabis dispensary for the first time can feel intimidating. You are not alone. Most people, in general and especially seniors, feel this way. Visiting a Medical Dispensary is your best bet. You will most likely want to avoid the recreational stores with blaring music, exaggerated branding, and, in general more of a party feel than what you will receive in a medical dispensary from a pharmacist well-versed in their cannabis products.

Here is your script to feel confident and get exactly what you need.

THE "FIRST VISIT" SCRIPT: When you arrive, introduce yourself clearly: "I am a senior citizen new to medical cannabis. I am looking for relief from [PAIN / SLEEP / ANXIETY]. I am concerned about feeling too 'high' or dizzy. Can you recommend a high-CBD, low-THC tincture, oil, edible, or topical to start?" OTHER KEY QUESTIONS TO ASK THE PHARMACIST:

1. "What is the ratio of THC to CBD in this product?" (Look for 1:1 or higher CBD). The 1 on the right is the CBD number. So a “One to Two” would be 1:2 and have half as much THC, or in other words, double the CBD.

2. "Is this product lab-tested for pesticides and heavy metals?" (You can ask for the Certificate of Analysis).

3. "Do you offer senior discounts or patient assistance programs?" WHAT TO BRING: - Your Medical Cannabis Certification/Card. - A notebook to write down product names and dosages.

4. “Is this Kosher?” We provide a guide for dispensaries that have access to Kosher Medical Cannabis.


SECTION 2: FINANCIAL TOOLKIT & COST SAVINGS Cannabis is an investment in your health, but it doesn't have to break the bank.

STRATEGIES FOR AFFORDABILITY:

1. Can I deduct Medical Cannabis on my taxes? In many jurisdictions, medical cannabis expenses can be deducted as a medical expense on your taxes if they exceed a certain percentage of your income. Contact us at CDONY for questions.

2. Senior Discounts: Many dispensaries offer discounts for seniors. Always ask!

3. Patient Assistance Programs: Organizations like the Patient Advocacy Foundation and state-specific programs often help cover costs for low-income seniors.

4. Compare Costs: Calculate the cost per day. Often, a $50 bottle of tincture lasts 30 days ($1.60/day), which is cheaper than a daily prescription pill that costs $5-$10.

5. Grow your own medicine. If you can, this is a great option CDONY has an article about.


SECTION 3: THE CAREGIVER'S HANDBOOK 

If you are a family member or caregiver, your role is vital. You are the guardian of safety and the bridge to healing. Contact us to get a full guide. Here is a brief intro:

YOUR RESPONSIBILITIES:

Storage: Keep medicine in a locked, child-proof container, away from grandchildren or pets.

Tracking: Help your loved one log their doses and effects. A simple notebook works wonders.

Observation: Watch for signs of over-sedation (extreme drowsiness, confusion) vs. therapeutic effect (relaxed, pain-free).

Advocacy: Be the voice if the senior is too tired or confused to speak up in sudden, environmentally difficult situations.

LEGAL NOTE: In many states, designated caregivers can legally pick up medicine for the patient. Check your state's specific laws.


SECTION 4: TRAVEL & TRANSPORTATION

Traveling with medical cannabis requires caution. ROAD TRIPS: - Keep medicine in its original, labeled container and read our reciprocity state list. Carry your Medical Card/Certification with you. Stick to state lines where cannabis is legal. Crossing state lines with cannabis is a federal crime. FLYING: CRITICAL WARNING: Do NOT fly with cannabis. TSA is a federal agency. Even if you have a medical card, flying with cannabis is illegal under federal law. Alternative: If you travel, research local dispensaries en route and at your destination, or leave the medicine at home.


SECTION 5: THE EMERGENCY PLAN 

What if something goes wrong? THE "GREEN OUT" PROTOCOL (Too much THC): If a senior feels anxious, dizzy, or paranoid:

1. Stay Calm: Reassure them that within a short time these effects will pass.

2. Hydrate: Drink water or an electrolyte water combination.

3. CBD Antidote: If available, take a dose of pure CBD to counteract the THC. CBD works wonders quickly to rebalance and quell the anxious/paranoid effect. 4. If prescribed: an anxiolytic like (clonazepam, valium, etc.) works well.

5. Grounding: Sit in a quiet, comfortable chair. Eat a snack. Many people have confirmed that smelling something strong, like coffee beans or a lemon peel, can also help.

6. Time: Wait it out. Effects usually peak in 1-2 hours and fade.


SECTION 6: YOUR TRUSTED PARTNER: CDONY & DR. KENNETH WIENBERG Navigating the medical system can be daunting. You need a guide who understands both the science and the unique needs of the senior patient. Why Choose CDONY (Cannabis Doctor of New York)? Led by Dr. Kenneth Wienberg, CDONY is not just a certification service; it is a comprehensive care partner and a leading voice in cannabis education. Expertise in Geriatrics: Dr. Wienberg specializes in understanding the complex physiology of aging, polypharmacy, and the specific needs of seniors. Personalized Care: They don't just sign a form. They create a tailored treatment plan based on your specific symptoms and medical history. Ongoing Support: CDONY provides continuous monitoring, dose adjustments, and education. They are there for you every step of the way. Thought Leadership: CDONY is home to industry experts whose articles provide deep insights into the latest scientific updates.


Get A New York State Medical Marijuana Card Fast.

Discover the Benefits with Cannabis Doctors of New York. How to Get Started:


We offer a vast range of appointments depending on your needs. You can now book fully online. Expedited appointments can be certified as quickly as 24 hours. You may request in-person or Telemed visits based on your needs. During your appointment, you will discuss whether medicating with cannabis is appropriate for you and review your medical history. This typically takes 20 - 30 minutes. Our physician will provide you with individualized guidance on products, doses, & dispensaries. Your appointment is securely booked through our HIPAA-compliant platform, and we never share your information.

Your privacy is our top priority, and all information submitted is encrypted and secured within our organization. We never share your information. Please fill out our secure intake form when scheduling your appointment. Our patient liaison will contact you to confirm your appointment.


To prepare for your appointment, we need to see proof of your New York State residency & proof of a medical condition. We can work with you to obtain the required documents. We can schedule your appointment once your records have been reviewed. If you have already gathered your documents, you may fax them to 212-784-6896 or upload them here, through our secure portal.

Our Patient Liaison and professional staff will help guide you through the process of obtaining your medical marijuana card in New York State. We help you determine eligibility, provide guidance for Medicaid/Medicare reimbursement, offer sliding scale fees according to income, and provide special rates for Veterans. We have expanded our practice to include facility coordination, dementia care, and other outreach programs where our specialists visit on-site locations in New York for patients residing in treatment or living facilities. Our Physician and Nurse Practitioner are available for personal follow-ups, consultations, and educational presentations. Follow us on Facebook for upcoming educational events and email us at info@cannabisdoctors.com




CONCLUSION: YOU ARE NOT ALONE in this journey; health is a team effort at CDONY. You have the wisdom, the plant has the power, and now you have the map. With these articles, you are well-equipped. Remember, you have a partner in Dr. Kenneth Wienberg and the Cannabis Doctors of New York team. Get started today, don't wait. Your golden years are meant to be vibrant, pain-free, and full of joy.

APPENDIX: QUICK CONTACTS & RESOURCES -

Cannabis Doctors of New York website: www.cdony.com

Meet Dr. Kenneth Wienberg: https://cdony.com/team

Read Greg Sondrol's Articles: https://cdony.com/blog/category/greg-sondrol

Patient Advocacy Foundation: https://www.patientadvocate.org

National Council on Aging (NCOA): https://www.ncoa.org

Bonus for the readers:)

Guide to the Cannabis Beginners Kit:

Water, CBD oil, snacks, a comfortable chair, a blanket, a pillow, a towel, “Occupied door handle hanger.” :)

- Greg Sondrol

Senior Cannabis Consultant

Sources for The Golden Age of Medical Cannabis Series:

  1. Gallup. (2024, November 1). What Percentage of Americans Smoke Marijuana? Gallup.Com. https://news.gallup.com/poll/284135/percentage-americans-smoke-marijuana.aspx 

  2. Al-Khazaleh, A. K., et al. (2024). The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects. Molecules, 29(2), Article 2. https://doi.org/10.3390/molecules29020410 

  3. Palamar, J. J., et al. (2025). Record High: Study Finds Growing Cannabis Use Among Older Adults. NYU School of Global Public Health. https://www.nyu.edu/about/news-publications/news/2025/june/cannabis-use-older-adults.html 

  4. Bilkei-Gorzo, A., et al. (2024). Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome. ACS Pharmacology & Translational Science, 7(9), 2637–2649. https://doi.org/10.1021/acsptsci.4c00002 

  5. Velayudhan, L., et al. (2024). Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD): A randomized, double-blind, placebo-controlled trial. International Psychogeriatrics. https://doi.org/10.1017/S1041610224000516 

  6. Gana, D., & Benavides, A. (2024, November 18). Anti-Aging Effects of Cannabis: A Comprehensive Review. BioSource Botanicals. https://biosourcebotanicals.com/anti-aging-effects-of-cannabis-a-comprehensive-review/ 

  7. Bell, A. D., et al. (2024). Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research, 9(2), 669–687. https://doi.org/10.1089/can.2021.0156 

  8. ScienceDaily. (2025, December 12). Scientists reveal the real benefits and hidden risks of medical cannabis. University of California - Los Angeles Health Sciences. https://www.sciencedaily.com/releases/2025/12/251211100620.htm 

  9. AARP. (2024, September 12). 1 in 5 Older Adults Use Cannabis. AARP. https://www.aarp.org/health/drugs-supplements/info-2024/cannabis-use-in-older-adults.html 

  10. Kim, J., et al. (2023). The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model. International Journal of Molecular Sciences, 24(7), Article 7. https://doi.org/10.3390/ijms24076827 

  11. Walsh, K. B., et al. (2021). Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in Pharmacology, 12, 777804. https://doi.org/10.3389/fphar.2021.777804 

  12. Arora, K., et al. (2021). Older Cannabis Users Are Not All Alike: Lifespan Cannabis Use Patterns. Journal of Applied Gerontology, 40(1), 87–94. https://doi.org/10.1177/0733464819894922 

  13. Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4311234/ 

  14. Khoj, L., et al. (2024). Effects of cannabis smoking on the respiratory system: A state-of-the-art review. Respiratory Medicine, 221. https://doi.org/10.1016/j.rmed.2023.107494 

  15. Pandelides, Z., et al. (2020). Developmental exposure to Δ9-tetrahydrocannabinol (THC) causes biphasic effects on longevity, inflammation, and reproduction in aged zebrafish. GeroScience, 42(3), 923–936. https://doi.org/10.1007/s11357-020-00175-3 

  16. Valeri, A., & Mazzon, E. (2021). Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration? Molecules, 26(20), 6313. https://doi.org/10.3390/molecules26206313 

  17. Ostir, G. V., et al. (2000). Emotional Well-Being Predicts Subsequent Functional Independence and Survival. Journal of the American Geriatrics Society, 48(5), 473–478. https://doi.org/10.1111/j.1532-5415.2000.tb04991.x 

  18. Russo, E. B. (2019). The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain," No Gain. Frontiers in Plant Science, 9. https://doi.org/10.3389/fpls.2018.01969 

  19. Suryavanshi, S. V., et al. (2021). Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective. Frontiers in Immunology, 11, 613613. https://doi.org/10.3389/fimmu.2020.613613 

  20. Timler, A., et al. (2020). Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: Study protocol for a double-blind randomised crossover trial. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC7023743/ 

  21. Ni, B., et al. (2023). The role of cannabidiol in aging. Biomedicine & Pharmacotherapy, 165, 115074. https://doi.org/10.1016/j.biopha.2023.115074 

  22. Malheiro, R. F., et al. (2023). Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics. Pharmacological Research, 187, 106603. https://doi.org/10.1016/j.phrs.2022.106603 

  23. Li, Z., et al. (2022). Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors. Free Radical Biology and Medicine, 180, 33–51. https://doi.org/10.1016/j.freeradbiomed.2022.01.001 

  24. Bilkei-Gorzo, A., et al. (2017). A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23(6), 782–787. https://doi.org/10.1038/nm.4311 

  25. Gęgotek, A., et al. (2023). The Anti-Inflammatory Action of Cannabigerol Accompanied by the Antioxidant Effect of 3-O-ethyl Ascorbic Acid in UVA-Irradiated Human Keratinocytes. Journal of Pharmacology and Experimental Therapeutics, 387(2), 170–179. https://doi.org/10.1124/jpet.123.001731 

  26. Han, B. H., & Palamar, J. J. (2020). Trends in Cannabis Use Among Older Adults in the United States, 2015-2018. JAMA Internal Medicine, 180(4), 609–611. https://doi.org/10.1001/jamainternmed.2019.7517 

  27.  https://doi.org/10.1016/j.ahj.2012.11.007 

  28. Ellingson, J. M., et al. (2021). The Neurocognitive Effects of Cannabis Across the Lifespan. Current Behavioral Neuroscience Reports, 8(4), 124. https://doi.org/10.1007/s40473-021-00244-7 

  29. Caulkins, J. P. (2024). Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction, 119(9), 1648–1652. https://doi.org/10.1111/add.16519 

  30. Terracciano, A., et al. (2008). Personality predictors of longevity: Activity, emotional stability, and conscientiousness. Psychosomatic Medicine, 70(6), 621–627. https://doi.org/10.1097/PSY.0b013e31817b9371 

  31. Suliman, N. A., et al. (2018). Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats. Neurotoxicity Research, 33(2), 402–411. https://doi.org/10.1007/s12640-017-9806-x 

  32. Weinstein, G., & Sznitman, S. R. (2020). The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Research Reviews, 59, 101041. https://doi.org/10.1016/j.arr.2020.101041 

  33. Yoo, H. B., et al. (2019). Interaction of Cannabis Use and Aging: From Molecule to Mind. Journal of Dual Diagnosis, 16(1), 140. https://doi.org/10.1080/15504263.2019.1665218 

  34. Siracusa, L., et al. (2023). Recent Research on Cannabis sativa L.: Phytochemistry, New Matrices, Cultivation Techniques, and Recent Updates on Its Brain-Related Effects (2018–2023). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10146690/ 

  35. Pocuca, N., et al. (2020). The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review. Archives of Clinical Neuropsychology, 36(5), 673–685. https://doi.org/10.1093/arclin/acaa105 

  36. O'Croinin, C., et al. (2023). Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativa. Pharmaceutics, 15(7), 1941. https://doi.org/10.3390/pharmaceutics15071941 

  37. Pandeliades, Z., et al. (2020). Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish. GeroScience, 42(2), 785–800. https://doi.org/10.1007/s11357-020-00182-4 

  38. Schulz, T. J., et al. (2007). Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress. Cell Metabolism, 6(4), 280–293. https://doi.org/10.1016/j.cmet.2007.08.001 

  39. Morsanuto, V., et al. (2020). A New Palmitoylethanolamide Form Combined with Antioxidant Molecules to Improve Its Effectivess on Neuronal Aging. Brain Sciences, 10(7), 457. https://doi.org/10.3390/brainsci10070457 

  40. Kataoka, K., et al. (2020). Age-dependent Alteration in Mitochondrial Dynamics and Autophagy in Hippocampal Neuron of Cannabinoid CB1 Receptor-deficient Mice. Brain Research Bulletin, 160, 40–49. https://doi.org/10.1016/j.brainresbull.2020.03.014 

  41. G, J., et al. (2023). Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants (Basel, Switzerland), 12(2). https://doi.org/10.3390/antiox12020485 

  42. Franceschi, C., et al. (2018). Inflammaging: A new immune--metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590. https://doi.org/10.1038/s41574-018-0059-4 

  43. Ebbert, J. O., et al. (2018). Medical Cannabis. Mayo Clinic Proceedings, 93(12), 1842–1847. https://doi.org/10.1016/j.mayocp.2018.09.005 

  44. Chacon, F. T., et al. (2022). Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy. Biomedicines, 10(12), 3142. https://doi.org/10.3390/biomedicines10123142 

  45. Bartschi, J. G., et al. (2023). Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2021.0209 

  46. Bahji, A., et al. (2022). Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: A mixed studies systematic review. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC8922797/ 

  47. Azcarate, P. M., et al. (2020). Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population. Journal of General Internal Medicine, 35(7), 1979–1986. https://doi.org/10.1007/s11606-020-05800-7 

  48. Aliev, G., et al. (2009). Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine, 13(2), 320–333. https://doi.org/10.1111/j.1582-4934.2008.00324.x 

  49. Ailshire, J. (2023). PATTERNS OF MARIJUANA USE IN THE US OLDER ADULT POPULATION. Innovation in Aging, 7(Suppl 1), 172. https://doi.org/10.1093/geroni/igad104.0564 

  50. A, D. S., et al. (2008). Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutation Research, 653(1–2). https://doi.org/10.1016/j.mrgentox.2008.04.004 

  51. 4.9: Eukaryotic Cells -- Mitochondria. (2018, July 5). Biology LibreTexts.

  52. Waddell, J. T. (2021). Age-varying time trends in cannabis- and alcohol-related risk perceptions 2002–2019. Addictive Behaviors, 124, 107091. https://doi.org/10.1016/j.addbeh.2021.107091 

  53. Ibrahim, I., et al. (2022). Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids. Metabolites, 12(12), 1247. https://doi.org/10.3390/metabo12121247 

  54. National Conference of State Legislatures. (2022). State Medical Cannabis Laws. https://bit.ly/3OgSL3j 

  55. Veriheal. (2024). What's the difference between hemp and marijuana? https://www.veriheal.com/blog/whats-the-difference-between-hemp-and-marijuana/ 

  56. Veriheal. (2024). Fastest-growing segment of the cannabis population. https://pmc.ncbi.nlm.nih.gov/articles/PMC8296849/

 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet
Add a rating
bottom of page